It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study.
source https://www.sciencedaily.com/releases/2024/10/241017112207.htm
Researchers discover how to turn one germ's drug resistance into an
Achilles' heel
-
Decades of reliance on the antibiotic rifampicin have fueled the rise of
drug-resistant Mycobacterium tuberculosis (Mtb). But as the bacterium
mutates to p...
3 hours ago
No comments:
Post a Comment